In the world economic growth, the Chondroitin Sulfate Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Chondroitin Sulfate market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Chondroitin Sulfate market size will be further expanded, we expect that by 2024, The market size of the Chondroitin Sulfate will reach XXX million $.
Chondroitin Sulfate Market Overview
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) comprised of a chain of alternating sugars. It is obtained from cartilages of poultry, bovine, porcine, fish, and sharks and also some times from avian and microbial sources. Chondroitin sulfate is majorly used to treat cataracts, osteoarthritis, urinary tract infections. The global chondroitin sulfate market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global chondroitin sulfate market is expected to witness significant growth during the forecast period, owing to increased application of chondroitin sulfate in several end-use industries.
Chondroitin Sulfate Market Drivers
Rising use of chondroitin sulfate in the treatment of joint pain, osteoporosis, and inflammation is expected to drive growth in the global chondroitin sulfate market during the forecast period. According to the International Osteoporosis Foundation, osteoporosis causes over 8.9 million fractures annually and is expected to affect around 75 million people in the U.S., Japan, and Europe. Chondroitin sulfate plays a major role in the treatment of osteoporosis, which in turn, is expected to drive growth of the global chondroitin sulfate market during the forecast period. Furthermore, increasing the use of shark-derived chondroitin in the treatment of arthritis wound healing, and eye complications are expected to propel the global chondroitin sulfate market growth over the forecast period.
Chondroitin Sulfate Market Restraint
Strict regulatory restrictions over-extraction of chondroitin sulfate from sharks since they are endangered species are expected to restrain growth of the global chondroitin sulfate market over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global chondroitin sulfate market during the forecast period. This is owing to the high growth of the pharmaceutical industry and rising product approvals by the U.S. Food and Drug Administration (FDA). Moreover, Asia Pacific is expected to register a lucrative growth rate over the forecast period, owing to the high prevalence of osteoporosis and rising consumer awareness in the region.
Competitive Section
Key players operating in the global chondroitin sulfate market are SANXIN, Sioux Pharm, WanTuMing Biological, Summit Nutritionals, TSI Group, GGI, Yantai Dongcheng, Flexion Therapeutics, Inc., Nippon Zoki, Focus Chem, Hengjie Bio-Pharmaceuticals, YBCC, Meitek (Synutra International), Runxin Biotechnology, QJBCHINA, ISBA, and Huiwen.
Key players in the market are focused on gaining product approvals from regulatory agencies, in order to expand the product portfolio. For instance, in October 2017, Flexion Therapeutics, Inc. received the U.S. FDA approval for its Zilretta intra-articular injection for osteoarthritis (OA) knee pain.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
✧ SANXIN
✧ WanTuMing Biological
✧ TSI Group
✧ Yantai Dongcheng
✧ Focus Chem
✧ YBCC
✧ Runxin Biotechnology
✧ ISBA
✧ Huiwen
✧ QJBCHINA
✧ Meitek (Synutra International)
✧ Hengjie Bio-Pharmaceuticals
✧ Nippon Zoki
✧ GGI
✧ Summit Nutritionals
✧ Sioux Pharm
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
✧ Food Grade
✧ Pharmaceutical Grade
Industry Segmentation:
✧ Pharmaceutical
✧ Dietary Supplements
✧ Cosmetics
✧ Veterinary Use
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
